Fatigue Assessment in Patients with Hereditary Hemochromatosis: First Use of the Popular Diagnostic Tools.

Autor: Świątczak, Michał¹ (AUTHOR) michal_swiatczak@gumed.edu.pl, Raczak, Alicja² (AUTHOR), Świątczak, Agata³ (AUTHOR), Młodziński, Krzysztof¹ (AUTHOR) krzysztofmlodzinski@gumed.edu.pl, Sikorska, Katarzyna⁴ (AUTHOR) ksikorska@gumed.edu.pl, Jaźwińska, Anna⁵ (AUTHOR) ania@gumed.edu.pl, Kaufmann, Damian¹ (AUTHOR) d.kaufmann@gumed.edu.pl, Daniłowicz-Szymanowicz, Ludmiła¹ (AUTHOR) ludwik@gumed.edu.pl

Publikováno v: Journal of Clinical Medicine. Sep2024, Vol. 13 Issue 18, p5544. 12p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics

Autor: Metges, J. P., Lebot, M. A., Faroux, R., Riaud, F., Gamelin, E., Capitain, O., Guérin Meyer, V., Leynia, P., Douillard, J. Y., Senellart, H., Rochard, S., Louvigné, C., Campion, L., Dupuis, O., Grollier, C., Achour, N. A., Person, B., Raoul, J. L., Boucher, E., Bertrand, C., Ramée, J. F., Guivarch, L., Etienne, P. L., Roussel, S., Desclos, H., Julien, M. N., Labarre, M. I., Klein, V., Bessard, R., Stampfli, C., Royet, F., Faycal, J., Gouva, S., Le Bihan, G., Couturier, M., Gourlaouen, A., Bertholom, C., Porneuf, M., Jobard, E., Peguet, E., Grasset, D., Bouret, J. F., Bicheler, V., Ulvoas, A., Miglianico, L., Chouzenoux, C., Deguiral, P., Derenne, L., Martin, D., Langlet, P. Michel, Bodin, C., Rossi, V., Barré, S., Cojocarasu, O., Naveau Ploux, C., Vidal, A. M., Cumin, I., Egreteau, J., Brouard, A., Matysiak Budnik, T., Thomaré, P., Le Bris Michel, A. S., Piriou, G., Largeau, R., Elhannani, C., Crespeau, E., Suberville, F., Bourgeois, H., Riche, C., Lagadec, D. Déniel, Marhuenda, F., Grudé, F.

Publikováno v: Oncologie (Paris, France)

In 2006, bevacizumab, a targeted therapy agent was combined with FOLFIRI for the firstline treatment of patients with unresectable metastatic colorectal cancer.A study on a homogenous series of 111 patients from the Brittany and Pays de la Loire area

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4f3734da8854bfed1a4708ad24b9c1cd

H. pylori and transient lower esophageal sphincter relaxations induced by gastric distension in healthy humans.

Autor: Zerbib F; Institut National de la Santé et de la Recherche Médicale U539, Human Nutrition Research Center, and Department of Gastroenterology and Hepatology, University of Nantes, 44035 Nantes, France., Bicheler V, Leray V, Joubert M, Bruley des Varannes S, Galmiche JP

Publikováno v: American journal of physiology. Gastrointestinal and liver physiology [Am J Physiol Gastrointest Liver Physiol] 2001 Aug; Vol. 281 (2), pp. G350-6.